Kunshengtai Medicine (02511.HK) announced that after consulting with relevant regional government departments, the group has decided to establish a production raw material operating base in Nandagang Industrial Park, Bohai New Area, Cangzhou City, Hebei Province. It is expected to fully utilize local preferential policies to establish and enhance the group's raw material production and supply capabilities at a better cost, to establish reliable strategic cooperation and partner relationships for the group's core products in China. Currently, it is actively communicating with local governments and stakeholders on business expansion plans, and will announce them in due course.
君聖泰醫藥(02511.HK)擬於河北滄州設立生產原材料營運主體基地
Junsengtai Pharmaceuticals (02511.HK) plans to establish a production and raw material operation base in Hebei Cangzhou.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.